nd uncertainties discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov
). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Contact: China Biologic Products, Inc.
Mr. Ming Yin
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
Financial statements follow.CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIESUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOMEFor the three months ended March 31, March 31, 20132012Sales
47,227,461Cost of sales16,616,75815,715,727Gross profit 37,414,97431,511,734Operating expenses Selling expenses1,836,3934,826,107General and administrative expenses 8,687,0977,145,794Research and development expenses 913,092710,588Income from operations 25,978,39218,829,245Other income (expenses)Equity in income of an equity method investee 128,9481,022,412Change in fair value of derivative liabilities -1,209,382Interest expense (236,174)(608,563)Interest income648,062543,395Other income (expenses), net -(100,989)Total othe
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Related medicine technology :1
|SOURCE China Biologic Products, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. China Botanic Pharmaceutical Inc. Announces Receipt of Delisting Notice2
. CPhI China 2013 Increases Customer Content Services and Expands Thanks to a Double Digit Pharma Industry Growth Rate and a Burgeoning Generics Market3
. Patent Issued In China For EntreMeds Lead Drug Candidate ENMD-20764
. China Biologic Products to Report First Quarter 2013 Financial Results5
. Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in China6
. China Nepstar Chain Drugstore Filed 2012 Annual Report on Form 20-F7
. MEDTEC China 2013: The Leading Medical Device Manufacturing Event in Asia Moves to a New Level8
. China Biologics Shandong Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Yaan Earthquake9
. Comparison of Biopharmaceutical Industry Between China and India 201310
. Chipscreen Biosciences Announces Achievement of Primary Endpoint in Chidamide Registrational Trial in China11
. China Regulatory and Market Access Pharmaceutical Report (2013)